U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247032) titled 'Prospective Real World Heart Failure Management for Patient With CIED Remotely Monitored' on Nov. 19.
Brief Summary: This randomized, controlled, open-label, parallel, multicenter clinical study evaluates the efficacy of SmartSignalHF compared with heart failure (HF) remote monitoring (RM) standard of care in implanted patients with heart failure. The primary objective is to determine whether SmartSignalHF reduces all-cause mortality and HF hospitalizations at 12 months.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Heart Failure
Heart Failure NYHA Class II
Heart Failure NYHA Class III
Heart Failure With Red...